204 related articles for article (PubMed ID: 26599105)
1. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
Mansouritorghabeh H; Shirdel A
J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
[TBL] [Abstract][Full Text] [Related]
2. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
3. Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII.
Shao Y; Wu W; Xu G; Wang X; Ding Q
Blood; 2019 Nov; 134(20):1745-1754. PubMed ID: 31558466
[TBL] [Abstract][Full Text] [Related]
4. Combined FV and FVIII deficiency.
Spreafico M; Peyvandi F
Haemophilia; 2008 Nov; 14(6):1201-8. PubMed ID: 19141160
[TBL] [Abstract][Full Text] [Related]
5. Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).
Devecioğlu O; Eryilmaz E; Celik D; Unüvar A; Karakaş Z; Anak S; Ağaoğlu L
Turk J Pediatr; 2002; 44(2):146-7. PubMed ID: 12026204
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
7. Combined factor V and factor VIII deficiency: a report of a case, genetic analysis, and response to desmopressin acetate.
Chapin J; Cardi D; Gibb C; Laurence J
Clin Adv Hematol Oncol; 2012 Jul; 10(7):472-4. PubMed ID: 22895291
[No Abstract] [Full Text] [Related]
8. Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran.
Karimi M; Cairo A; Safarpour MM; Haghpanah S; Ekramzadeh M; Afrasiabi A; Shahriari M; Menegatti M
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):360-3. PubMed ID: 24389588
[TBL] [Abstract][Full Text] [Related]
9. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.
White B; Lawler P; Riddell A; Nitu-Whalley IC; Hermans C; Lee CA; Brown SA
Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739
[TBL] [Abstract][Full Text] [Related]
10. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
Garcia VV; Silva IA; Borrasca AL
Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
[TBL] [Abstract][Full Text] [Related]
12. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
13. Combined Factor V and Factor VIII Deficiency.
Spreafico M; Peyvandi F
Semin Thromb Hemost; 2009 Jun; 35(4):390-9. PubMed ID: 19598067
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
16. Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A.
Ragni MV; Novelli EM; Murshed A; Merricks EP; Kloos MT; Nichols TC
Thromb Haemost; 2013 Feb; 109(2):248-54. PubMed ID: 23238591
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
Lethagen S
Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
[TBL] [Abstract][Full Text] [Related]
18. DDAVP challenge tests in boys with mild/moderate haemophilia A.
Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
[TBL] [Abstract][Full Text] [Related]
19. Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses.
Mannucci PM; Vicente V; Alberca I; Sacchi E; Longo G; Harris AS; Lindquist A
Thromb Haemost; 1987 Dec; 58(4):1037-9. PubMed ID: 3127916
[TBL] [Abstract][Full Text] [Related]
20. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.
Rose EH; Aledort LM
Ann Intern Med; 1991 Apr; 114(7):563-8. PubMed ID: 1900403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
